Glutathione levels may decline due to aging, chronic stress, illness, or environmental exposures
Overall wellbeing improvements stabilize
When combined with cyclophosphamide, NPLD is effectively used in the treatment of metastatic breast cancer [71]
Peptide therapy may not be recommended for individuals with active or recent cancer, pregnant or breastfeeding women, people with known copper metabolism disorders, severe uncontrolled medical conditions, or those seeking unsupervised self-administration
The peptide enhances sleep quality, particularly slow-wave (deep) sleep phases when natural growth hormone secretion normally peaks
Potential Side Effects Although both peptides are well-tolerated, some patients may experience: Mild water retention Joint stiffness (temporary) Insulin sensitivity changes (rare) Injection site irritation Patients should always be monitored by a physician trained in peptide therapy, and adjustments can be made to dose or frequency to mitigate any issues
.jpg)
